CJC-1295 NON DAC 2 mg x 5 Vials – HUMA Peptide

HUMA Peptide CJC-1295 NON DAC 2 mg is a premium research peptide formulated with CJC-1295 without DAC, a modified Growth Hormone Releasing Hormone (GHRH) analogue extensively studied for its short-acting interaction with growth hormone signaling pathways. Unlike the DAC version, CJC-1295 NON DAC is commonly researched for its rapid activity profile, making it a valuable tool for scientists investigating pulsatile hormone release, peptide pharmacodynamics, endocrine regulation, and receptor-mediated signaling.

Each pack includes 5 lyophilized vials, with 2 mg of CJC-1295 NON DAC per vial, providing researchers with a convenient multi-vial format for advanced laboratory applications. Manufactured to strict research standards, HUMA Peptide CJC-1295 NON DAC offers exceptional purity, consistency, and stability, supporting precise peptide investigations in controlled scientific environments.

Developed for modern peptide science, this high-quality formulation is ideal for researchers exploring growth hormone physiology, cellular communication, peptide synergy, and endocrine biology.

Key Features

• Premium CJC-1295 NON DAC research peptide
• 2 mg of high-purity peptide per vial
• 5 lyophilized vials per pack
• Short-acting Growth Hormone Releasing Hormone (GHRH) analogue
• High-purity research-grade formulation
• Commonly studied in growth hormone and endocrine pathway research
• Suitable for investigations involving pulsatile hormone signaling and peptide pharmacodynamics
• Manufactured under strict quality standards
• Intended exclusively for laboratory and scientific research applications

Contents

Active Ingredient: CJC-1295 NON DAC – 2 mg

Packaging: 5 Lyophilized Vials